Sanofi and Regeneron’s Praluent may still not be cost effective compared to other cholesterol-lowering drugs despite a recent price cut, a new study has claimed. The drug's high price point has ...

Praluent is a prescription drug used for certain conditions, including high cholesterol. Find out about possible interactions ...

2017 could not have started worse for Sanofi – already under pressure due to falling insulin sales, a court has banned it from selling its cholesterol drug Praluent in the US, after finding it ...

Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators ...